Patients A glance back to Pharma Integrates, London 2022 – part ii Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022.
News A glance back to Pharma Integrates 2022 – part i Run by Life Science Integrates, Pharma Integrates was in its eleventh year in 2022.
News Roche's oral MS hope fenebrutinib hits the mark in phase 3 Roche's oral BTK inhibitor fenebrutinib is on track for filings next year for multiple sclerosis after clearing two phase 3 trials.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
